346 related articles for article (PubMed ID: 19703758)
1. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
3. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
[TBL] [Abstract][Full Text] [Related]
4. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
6. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
8. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.
Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA
J Biol Chem; 2011 Jun; 286(25):22665-77. PubMed ID: 21536666
[TBL] [Abstract][Full Text] [Related]
10. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
11. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
12. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
14. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activation in venous leg ulcers.
Herouy Y; Trefzer D; Hellstern MO; Stark GB; Vanscheidt W; Schöpf E; Norgauer J
Br J Dermatol; 2000 Nov; 143(5):930-6. PubMed ID: 11069499
[TBL] [Abstract][Full Text] [Related]
16. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
[TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
[TBL] [Abstract][Full Text] [Related]
19. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.
Kobayashi N; Ueno T; Ohashi K; Yamashita H; Takahashi Y; Sakamoto K; Manabe S; Hara S; Takashima Y; Dan T; Pastan I; Miyata T; Kurihara H; Matsusaka T; Reiser J; Nagata M
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F614-26. PubMed ID: 25587125
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]